vs
Side-by-side financial comparison of FutureFuel Corp. (FF) and DNA X, Inc. (SONM). Click either name above to swap in a different company.
FutureFuel Corp. is the larger business by last-quarter revenue ($19.8M vs $16.2M, roughly 1.2× DNA X, Inc.). DNA X, Inc. runs the higher net margin — -29.3% vs -60.5%, a 31.2% gap on every dollar of revenue. On growth, DNA X, Inc. posted the faster year-over-year revenue change (7.9% vs -67.7%). Over the past eight quarters, DNA X, Inc.'s revenue compounded faster (9.9% CAGR vs -41.7%).
FutureFuel Corporation is a developer and producer of chemicals and biofuels. It is listed on the New York Stock Exchange, with symbol FF.
FF vs SONM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.8M | $16.2M |
| Net Profit | $-12.0M | $-4.8M |
| Gross Margin | -46.7% | 11.2% |
| Operating Margin | -62.9% | -24.5% |
| Net Margin | -60.5% | -29.3% |
| Revenue YoY | -67.7% | 7.9% |
| Net Profit YoY | -529.4% | -89.2% |
| EPS (diluted) | $-0.28 | $-4.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.8M | — | ||
| Q3 25 | $22.7M | $16.2M | ||
| Q2 25 | $35.7M | $11.2M | ||
| Q1 25 | $17.5M | $16.7M | ||
| Q4 24 | $61.5M | $15.3M | ||
| Q3 24 | $51.1M | $15.0M | ||
| Q2 24 | $72.4M | $11.5M | ||
| Q1 24 | $58.3M | $9.1M |
| Q4 25 | $-12.0M | — | ||
| Q3 25 | $-9.3M | $-4.8M | ||
| Q2 25 | $-10.4M | $-7.5M | ||
| Q1 25 | $-17.6M | $458.0K | ||
| Q4 24 | $2.8M | $-21.6M | ||
| Q3 24 | $-1.2M | $-2.5M | ||
| Q2 24 | $9.6M | $-6.6M | ||
| Q1 24 | $4.3M | $-2.9M |
| Q4 25 | -46.7% | — | ||
| Q3 25 | -30.1% | 11.2% | ||
| Q2 25 | -24.6% | 7.6% | ||
| Q1 25 | -83.0% | 50.0% | ||
| Q4 24 | 9.1% | -1.2% | ||
| Q3 24 | 0.7% | 28.2% | ||
| Q2 24 | 12.0% | 25.8% | ||
| Q1 24 | 8.6% | 31.8% |
| Q4 25 | -62.9% | — | ||
| Q3 25 | -42.9% | -24.5% | ||
| Q2 25 | -33.4% | -60.2% | ||
| Q1 25 | -107.4% | 3.9% | ||
| Q4 24 | 2.6% | 55.3% | ||
| Q3 24 | -5.6% | -15.8% | ||
| Q2 24 | 7.5% | -56.2% | ||
| Q1 24 | 3.8% | -29.5% |
| Q4 25 | -60.5% | — | ||
| Q3 25 | -41.1% | -29.3% | ||
| Q2 25 | -29.2% | -66.8% | ||
| Q1 25 | -100.6% | 2.7% | ||
| Q4 24 | 4.5% | -141.6% | ||
| Q3 24 | -2.3% | -16.7% | ||
| Q2 24 | 13.2% | -57.5% | ||
| Q1 24 | 7.4% | -31.9% |
| Q4 25 | $-0.28 | — | ||
| Q3 25 | $-0.21 | $-4.83 | ||
| Q2 25 | $-0.24 | $-0.79 | ||
| Q1 25 | $-0.40 | $0.08 | ||
| Q4 24 | $0.06 | $-116.99 | ||
| Q3 24 | $-0.03 | $-9.32 | ||
| Q2 24 | $0.22 | $-1.41 | ||
| Q1 24 | $0.10 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $51.3M | $2.1M |
| Total DebtLower is stronger | — | $5.1M |
| Stockholders' EquityBook value | $154.7M | $-701.0K |
| Total Assets | $192.2M | $40.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $51.3M | — | ||
| Q3 25 | $85.6M | $2.1M | ||
| Q2 25 | $95.2M | $2.0M | ||
| Q1 25 | $97.1M | $2.1M | ||
| Q4 24 | $109.5M | $5.3M | ||
| Q3 24 | $133.4M | $9.1M | ||
| Q2 24 | $115.1M | $9.6M | ||
| Q1 24 | $201.1M | $9.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | $5.1M | ||
| Q2 25 | — | $2.9M | ||
| Q1 25 | — | $2.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $154.7M | — | ||
| Q3 25 | $169.1M | $-701.0K | ||
| Q2 25 | $178.2M | $-1.3M | ||
| Q1 25 | $188.4M | $-1.1M | ||
| Q4 24 | $205.8M | $-5.7M | ||
| Q3 24 | $213.3M | $15.3M | ||
| Q2 24 | $214.4M | $17.5M | ||
| Q1 24 | $204.8M | $19.8M |
| Q4 25 | $192.2M | — | ||
| Q3 25 | $203.5M | $40.2M | ||
| Q2 25 | $218.2M | $36.1M | ||
| Q1 25 | $227.7M | $36.0M | ||
| Q4 24 | $247.7M | $39.7M | ||
| Q3 24 | $256.5M | $49.1M | ||
| Q2 24 | $261.2M | $45.9M | ||
| Q1 24 | $365.4M | $42.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-27.4M | $-7.0M |
| Free Cash FlowOCF − Capex | $-29.9M | — |
| FCF MarginFCF / Revenue | -150.5% | — |
| Capex IntensityCapex / Revenue | 12.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-46.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-27.4M | — | ||
| Q3 25 | $-1.1M | $-7.0M | ||
| Q2 25 | $5.2M | $-4.9M | ||
| Q1 25 | $-5.4M | $-9.6M | ||
| Q4 24 | $-16.6M | $-4.5M | ||
| Q3 24 | $25.8M | $-417.0K | ||
| Q2 24 | $27.8M | $-3.4M | ||
| Q1 24 | $-12.2M | $-168.0K |
| Q4 25 | $-29.9M | — | ||
| Q3 25 | $-6.5M | — | ||
| Q2 25 | $-263.0K | — | ||
| Q1 25 | $-9.4M | — | ||
| Q4 24 | $-20.7M | $-4.5M | ||
| Q3 24 | $20.5M | $-554.0K | ||
| Q2 24 | $24.8M | $-3.4M | ||
| Q1 24 | $-14.5M | $-198.0K |
| Q4 25 | -150.5% | — | ||
| Q3 25 | -28.5% | — | ||
| Q2 25 | -0.7% | — | ||
| Q1 25 | -53.6% | — | ||
| Q4 24 | -33.6% | -29.6% | ||
| Q3 24 | 40.1% | -3.7% | ||
| Q2 24 | 34.3% | -29.8% | ||
| Q1 24 | -24.9% | -2.2% |
| Q4 25 | 12.2% | — | ||
| Q3 25 | 23.5% | — | ||
| Q2 25 | 15.3% | — | ||
| Q1 25 | 22.8% | — | ||
| Q4 24 | 6.6% | 0.1% | ||
| Q3 24 | 10.4% | 0.9% | ||
| Q2 24 | 4.1% | 0.3% | ||
| Q1 24 | 3.9% | 0.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -20.97× | ||
| Q4 24 | -5.94× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.90× | — | ||
| Q1 24 | -2.82× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FF
| Chemicals | $18.0M | 91% |
| Biofuels | $1.8M | 9% |
SONM
Segment breakdown not available.
